The COVID-19 Prevention Network (CoVPN) is part of a nationwide effort to develop effective treatments for COVID-19. Established by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID), CoVPN is helping country-wide networks of infectious disease experts and their global partners coordinate large Phase 3 trials for potential vaccines and monoclonal antibodies (mAbs) for prevention of COVID-19.
To recruit the diverse pool of volunteers needed to conduct these trials, NIAID asked a Booz Allen digital transformation team to build a website that would allow CoVPN to support the enrollment of a large volume of volunteer applications for a registry for Phase 3 trials taking place across the country as well as to educate the public on the science of vaccines and mAbs.
Using a design system we created to comply with federal digital policy, we helped NIAID design and launch CoronavirusPreventionNetwork.org in 5 weeks. In its first 2 months of operation, this secure, user-friendly website and its Spanish-language version received more than 6.4 million page views and enabled more than 400,000 people to sign up as volunteers.